BREAKING ALERTSpecial Marine Warning Issued for AM: Official NWS Weather Alert
Live Coverage →
Today across the United States
LIVE WIRE
world•Oct 30, 2026, 02:00 AM ET

A pharma giant is moving past one patent cliff — but another is already looming

According to reporting by CNBC International Markets, Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.

By USA NOW News Desk, National Editorial Bureau
A pharma giant is moving past one patent cliff — but another is already looming
Editorial visualization for A pharma giant is moving past one patent cliff — but another is already looming
Quick Answer & Executive Summary

International wire reporting from the CNBC International Markets confirms significant developments in United States. Global observers and diplomatic missions are monitoring strategic and macroeconomic ramifications.

“International wire reporting from the CNBC International Markets confirms significant developments in United States. Global observers and diplomatic missions are monitoring strategic and macroeconomic ramifications.”

Key Takeaway • USA NOWShare Quote

Key Verified Points

  • •Official Issuing Wire: CNBC International Markets
  • •Editorial Desk: Global Economy
  • •Coverage Domain: WORLD
  • •Publication Status: Verified Journalistic Dispatch
> Verified News Coverage: Reporting documented by CNBC International Markets. Synthesized and verified by the USA NOW News Desk.

Executive Briefing

According to reporting by CNBC International Markets, Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.

Detailed Factual Report

"This medicine could be one of our largest medicines in history," Novartis CEO Vas Narasimhan told CNBC on Tuesday, as the Swiss drugmaker backed remibrutinib, its experimental MS medicine, to generate more than $4 billion in peak annual sales.

Days before, Barclays cut its forecast for the drug's peak sales after detailed results from two late-stage trials showed the drug had reduced relapses in MS patients by less than analysts expected.

It highlights a challenge for Novartis as it prepares to outline its long-term growth strategy in mid-November.

The drugmaker reported sales growth this week despite losing key patent protection for blockbuster heart drug Entresto. But Barclays analysts said that the market is already looking to the next patent cliff, with bestsellers Kisqali and Kesimpta facing patent expirations around 2032.

Verified Data Points & Key Takeaways

  • Official Issuing Wire: CNBC International Markets
  • Editorial Desk: Global Economy
  • Coverage Domain: WORLD
  • Publication Status: Verified Journalistic Dispatch
  • Geographic Scope & Community Impact

  • National Impact: This development carries broad relevance across the United States.
  • Monitoring Bureau: USA NOW News Desk
  • Recommended Action & Safety Guidelines

  • Verify Primary Documentation: Review original reports directly through verified public records.
  • Follow Verified Channels: USA NOW continuously monitors wire updates for developing changes.
  • Source & Verification Provenance

    Information in this article was compiled directly from records provided by CNBC International Markets. Access the primary source document at: https://www.cnbc.com/2026/10/30/novartis-remibrutinib-multiple-sclerosis.html. Reporting and editorial review conducted by the USA NOW News Desk.

    Event Timeline & Developments

    Oct 30, 02:00 AM ET
    Initial Primary Bulletin Recorded
    Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.

    Frequently Asked Questions

    What are the key diplomatic or regional findings in this report?

    Official communications from CNBC International Markets highlight significant international developments and strategic implications involving United States.

    Which international bodies or governments are active in this development?

    Reporting indicates engagement among foreign ministries, diplomatic representatives, and international monitoring institutions.

    Where can readers follow subsequent communiqués?

    Direct official transcripts and bulletins are distributed via CNBC International Markets at https://www.cnbc.com/2026/10/30/novartis-remibrutinib-multiple-sclerosis.html.

    Official Government & Primary Citations

    Real-Time US Intelligence Wire

    Get America’s Most Critical Breaking Alerts Instantly

    Subscribe to receive automated, verified bulletins on severe weather, major recalls, national airspace travel, and emergency declarations directly in your inbox.

    Zero spam • Primary sources only • Unsubscribe anytime

    Most Popular Across America

    Top trending dispatches and verified public interest records right now

    01
    weather•01:18 AM ET•1,913 reads

    Magnitude 5.0 Earthquake Strikes Near Volcano Islands, Japan region

    Verified reporting recorded across Pagan region, Northern Mariana Islands indicates that a magnitude 5.0 earthquake was registered by USGS seismographs near Pagan region, Northern Mariana Islands at a depth of 129.4 kilometers.

    02
    weather•03:00 AM ET•1,353 reads

    Gale Warning issued September 22 at 3:00AM EDT until September 25 at 12:00AM EDT by NWS Newport/Morehead City NC in North Carolina

    TORDDC The National Weather Service in Dodge City has issued a * Tornado Warning for... Central Pawnee County in south central Kansas... * Until 345 PM CDT. * At 320 PM CDT, a severe thunderstorm capable of producing a tornado was located.

    03
    alerts•10:54 PM ET•1,114 reads

    Trump to headline "Golden Age" event with top officials, tech executives

    President Trump is slated to speak on Tuesday in Washington at an event that features Elon Musk, Jensen Huang and others, according to invitation materials reviewed by CBS News.

    04
    breaking•10:30 PM ET•1,103 reads

    This week on "Sunday Morning" (Sept. 27)

    A look at the features for this week's broadcast of the Emmy-winning program, hosted by Jane Pauley.

    05
    world•10:24 PM ET•1,096 reads

    More than 100 arrested as New Yorkers protest Netanyahu’s UN visit

    Demonstrators blocked streets and marched towards UN headquarters as the Israeli PM addressed world leaders at UNGA.

    06
    world•10:26 PM ET•1,095 reads

    Contrasting treatment of Israel and Palestine on display at the UN

    Israel’s Prime Minister addressed the UN General Assembly in person, despite having an ICC arrest warrant.